Virtus ETF Advisers LLC Lexicon Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 179,972 shares of LXRX stock, worth $149,376. This represents 0.14% of its overall portfolio holdings.

Number of Shares

179,972

Previous 179,972 -0.0%

Holding current value

$149,376

Previous $302,000 6.62%

% of portfolio

0.14%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.54 - $2.28 $174,204 - $257,913	-113,120 Reduced 38.6%	179,972 $302,000
Q1 2024 May 15, 2024	BUY	$1.3 - $3.58 $54,819 - $150,965	42,169 Added 16.81%	293,092 $703,000
Q4 2023 Feb 15, 2024	BUY	$1.0 - $1.53 $129,212 - $197,694	129,212 Added 106.16%	250,923 $383,000
Q3 2023 Nov 07, 2023	SELL	$1.06 - $2.33 $16,683 - $36,671	-15,739 Reduced 11.45%	121,711 $132,000
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.49 $295,517 - $479,700	137,450 New	137,450 $314,000
Q2 2022 Aug 12, 2022	SELL	$1.31 - $2.69 $51,433 - $105,614	-39,262 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.95 - $3.89 $4,527 - $9,032	-2,322 Reduced 5.58%	39,262 $82,000
Q4 2021 Feb 14, 2022	SELL	$3.81 - $6.16 $10,645 - $17,211	-2,794 Reduced 6.3%	41,584 $164,000
Q3 2021 Nov 15, 2021	SELL	$3.38 - $5.35 $7,844 - $12,417	-2,321 Reduced 4.97%	44,378 $213,000
Q2 2021 Aug 10, 2021	BUY	$4.12 - $5.87 $192,399 - $274,123	46,699 New	46,699 $214,000
Q2 2020 Aug 05, 2020	SELL	$1.75 - $2.3 $211,872 - $278,461	-121,070 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$1.8 - $4.28 $18,388 - $43,724	-10,216 Reduced 7.78%	121,070 $236,000
Q4 2019 Feb 13, 2020	BUY	$3.16 - $5.15 $27,277 - $44,454	8,632 Added 7.04%	131,286 $545,000
Q3 2019 Nov 12, 2019	SELL	$1.2 - $6.66 $24,741 - $137,315	-20,618 Reduced 14.39%	122,654 $369,000
Q2 2019 Aug 13, 2019	BUY	$5.35 - $7.11 $766,505 - $1.02 Million	143,272 New	143,272 $901,000
Q1 2019 May 14, 2019	SELL	$4.36 - $7.94 $358,806 - $653,422	-82,295 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$6.15 - $10.51 $132,637 - $226,669	21,567 Added 35.51%	82,295 $546,000
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $42,229 - $53,441	4,092 Added 7.23%	60,728 $648,000
Q2 2018 Aug 10, 2018	SELL	$7.8 - $13.69 $259,030 - $454,631	-33,209 Reduced 36.96%	56,636 $680,000
Q1 2018 May 14, 2018	SELL	$7.86 - $11.39 $41,139 - $59,615	-5,234 Reduced 5.5%	89,845 $770,000
Q4 2017 Feb 14, 2018	BUY	$8.77 - $12.28 $663,073 - $928,453	75,607 Added 388.29%	95,079 $939,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $21,674 - $29,030	1,781 Added 10.07%	19,472 $239,000
Q2 2017 Aug 14, 2017	BUY	N/A	17,691	17,691 $291,000

Others Institutions Holding LXRX

# of Institutions

141

Shares Held

238M

Call Options Held

459K

Put Options Held

133K

View Full List

About LEXICON PHARMACEUTICALS, INC.

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

More about LXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Lexicon Pharmaceuticals, Inc. Transaction History